Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
About this study
This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.
- Condition
- End of Life, Cancer
- Tested
- Receive technology-based supportive cancer care, Receive redesigned team-based supportive cancer care
- Sponsor
- Stanford University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Study condition: End of Life, Cancer
- Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
- Patients must have the ability to understand and willingness to provide verbal consent.
- Participants must speak English, Spanish, Chinese, or Vietnamese.
Exclusion 4
- Inability to consent to the study
- Plans to change oncologist within 12 months
- Employed by the practice site
- Patients who anticipate moving from the area within 12 months
Where
17 sites, 12 recruiting
University of Alabama at Birmingham
Birmingham, Alabama, United States
Beckman Research Institute of City of Hope
Duarte, California, United States
VA Medical Center, Fresno
Fresno, California, United States
Santa Clara Valley Medical Center
Fruitdale, California, United States
St Jude Heritage Medical Group
Fullerton, California, United States
Spark M. Matsunaga VA Medical Center
Honolulu, Hawaii, United States
and 11 more sites on ClinicalTrials.gov
Contact
-
Manali I Patel, MD MPH MS
6507234000 manalip@stanford.edu
Potential match only. Final eligibility is determined by the study team.